These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1357114)

  • 1. GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomography.
    Dewey SL; Smith GS; Logan J; Brodie JD; Yu DW; Ferrieri RA; King PT; MacGregor RR; Martin TP; Wolf AP
    J Neurosci; 1992 Oct; 12(10):3773-80. PubMed ID: 1357114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Striatal binding of the PET ligand 11C-raclopride is altered by drugs that modify synaptic dopamine levels.
    Dewey SL; Smith GS; Logan J; Brodie JD; Fowler JS; Wolf AP
    Synapse; 1993 Apr; 13(4):350-6. PubMed ID: 8480281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects.
    Dewey SL; Smith GS; Logan J; Brodie JD; Simkowitz P; MacGregor RR; Fowler JS; Volkow ND; Wolf AP
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11816-20. PubMed ID: 8265632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis.
    Dewey SL; Smith GS; Logan J; Alexoff D; Ding YS; King P; Pappas N; Brodie JD; Ashby CR
    J Neurosci; 1995 Jan; 15(1 Pt 2):821-9. PubMed ID: 7823183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging dopamine release with Positron Emission Tomography (PET) and (11)C-raclopride in freely moving animals.
    Patel VD; Lee DE; Alexoff DL; Dewey SL; Schiffer WK
    Neuroimage; 2008 Jul; 41(3):1051-66. PubMed ID: 18442926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonergic modulation of dopamine measured with [11C]raclopride and PET in normal human subjects.
    Smith GS; Dewey SL; Brodie JD; Logan J; Vitkun SA; Simkowitz P; Schloesser R; Alexoff DA; Hurley A; Cooper T; Volkow ND
    Am J Psychiatry; 1997 Apr; 154(4):490-6. PubMed ID: 9090335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of lorazepam administration on striatal dopamine D2 receptor binding characteristics in man--a positron emission tomography study.
    Hietala J; Kuoppamäki M; Någren K; Lehikoinen P; Syvälahti E
    Psychopharmacology (Berl); 1997 Aug; 132(4):361-5. PubMed ID: 9298513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography studies of potential mechanisms underlying phencyclidine-induced alterations in striatal dopamine.
    Schiffer WK; Logan J; Dewey SL
    Neuropsychopharmacology; 2003 Dec; 28(12):2192-8. PubMed ID: 12888780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.
    Ginovart N; Galineau L; Willeit M; Mizrahi R; Bloomfield PM; Seeman P; Houle S; Kapur S; Wilson AA
    J Neurochem; 2006 May; 97(4):1089-103. PubMed ID: 16606355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitation of carbon-11-labeled raclopride in rat striatum using positron emission tomography.
    Hume SP; Myers R; Bloomfield PM; Opacka-Juffry J; Cremer JE; Ahier RG; Luthra SK; Brooks DJ; Lammertsma AA
    Synapse; 1992 Sep; 12(1):47-54. PubMed ID: 1411963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PET.
    Tedroff J; Pedersen M; Aquilonius SM; Hartvig P; Jacobsson G; Långström B
    Neurology; 1996 May; 46(5):1430-6. PubMed ID: 8628494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756.
    Abi-Dargham A; Simpson N; Kegeles L; Parsey R; Hwang DR; Anjilvel S; Zea-Ponce Y; Lombardo I; Van Heertum R; Mann JJ; Foged C; Halldin C; Laruelle M
    Synapse; 1999 May; 32(2):93-109. PubMed ID: 10231129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of striatal D2 dopamine receptor density and affinity with [11C]-raclopride in vivo: a test-retest analysis.
    Hietala J; Någren K; Lehikoinen P; Ruotsalainen U; Syvälahti E
    J Cereb Blood Flow Metab; 1999 Feb; 19(2):210-7. PubMed ID: 10027776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography demonstrates dopamine D2 receptor supersensitivity in the striatum of patients with early Parkinson's disease.
    Rinne UK; Laihinen A; Rinne JO; Någren K; Bergman J; Ruotsalainen U
    Mov Disord; 1990; 5(1):55-9. PubMed ID: 2136932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride.
    Narendran R; Hwang DR; Slifstein M; Talbot PS; Erritzoe D; Huang Y; Cooper TB; Martinez D; Kegeles LS; Abi-Dargham A; Laruelle M
    Synapse; 2004 Jun; 52(3):188-208. PubMed ID: 15065219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the substituted (S)-3-phenylpiperidine (-)-OSU6162 on PET measurements of [11C]SCH23390 and [11C]raclopride binding in primate brains.
    Ekesbo A; Torstenson R; Hartvig P; Carlsson A; Sonesson C; Waters N; Tedroff J; Långström B
    Neuropharmacology; 1999 Mar; 38(3):331-8. PubMed ID: 10219971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of reserpine-induced depletion of synaptic dopamine on [11C]raclopride binding to D2-dopamine receptors in the monkey brain.
    Ginovart N; Farde L; Halldin C; Swahn CG
    Synapse; 1997 Apr; 25(4):321-5. PubMed ID: 9097390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-desmethoxyfallypride: a fluorine-18 labeled radiotracer with properties similar to carbon-11 raclopride for PET imaging studies of dopamine D2 receptors.
    Mukherjee J; Yang ZY; Brown T; Roemer J; Cooper M
    Life Sci; 1996; 59(8):669-78. PubMed ID: 8761017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDMA-evoked changes in [11C]raclopride and [11C]NMSP binding in living pig brain.
    Rosa-Neto P; Gjedde A; Olsen AK; Jensen SB; Munk OL; Watanabe H; Cumming P
    Synapse; 2004 Sep; 53(4):222-33. PubMed ID: 15266554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method.
    Breier A; Su TP; Saunders R; Carson RE; Kolachana BS; de Bartolomeis A; Weinberger DR; Weisenfeld N; Malhotra AK; Eckelman WC; Pickar D
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2569-74. PubMed ID: 9122236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.